42 results on '"Martinez-Sobrido, Luis"'
Search Results
2. SARS-CoV-2 nsp15 endoribonuclease antagonizes dsRNA-induced antiviral signaling
3. The SARS-CoV-2 Spike is a virulence determinant and plays a major role on the attenuated phenotype of Omicron virus in a feline model of infection
4. Antivirals against monkeypox infections
5. Global landscape of the host response to SARS-CoV-2 variants reveals viral evolutionary trajectories
6. Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis
7. Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors
8. Monitoring SARS-CoV-2 infection using a double reporter-expressing virus
9. Using a reverse genetics system to generate recombinant SARS-CoV-2 expressing robust levels of reporter genes
10. Numb-associated kinases are required for SARS-CoV-2 infection and are cellular targets for therapy
11. Immunization with recombinant accessory protein-deficient SARS-CoV-2 protects against lethal challenge and viral transmission
12. Potent universal-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibody
13. Vaccinia virus attenuation by codon deoptimization of the A24R gene for vaccine development
14. A single amino acid substitution in PB1 of pandemic H1N1 with A/Ann Arbor/6/60 master donor virus mutations as a novel live-attenuated influenza virus vaccine
15. Characterization of the significant decline in humoral immune response six months post-SARS-CoV-2 mRNA vaccination: A systematic review
16. Effects of Age, Sex, Serostatus and Underlying Comorbidities on Humoral Response Post-SARS-CoV-2 Pfizer-BioNTech Vaccination – A Systematic Review
17. SARS-CoV-2 hijacks p38β/MAPK11 to promote virus replication
18. A SARS-CoV-2 nucleocapsid protein TR-FRET assay amenable to high-throughput screening
19. A bifluorescent-based assay for the identification of neutralizing antibodies against SARS-CoV-2 variants of concern in vitro and in vivo
20. Visualization of SARS-CoV-2 infection dynamic
21. 4’-Fluorouridine is a broad-spectrum orally efficacious antiviral blocking respiratory syncytial virus and SARS-CoV-2 replication
22. Anticancer pan-ErbB inhibitors reduce inflammation and tissue injury and exert broad-spectrum antiviral effects
23. Modeling SARS-CoV-2 and Influenza Infections and Antiviral Treatments in Human Lung Epithelial Tissue Equivalents
24. SARS-CoV-2 B.1.1.7 and B.1.351 variants of concern induce lethal disease in K18-hACE2 transgenic mice despite convalescent plasma therapy
25. Amino acid residues involved in inhibition of host gene expression by influenza A/Brevig Mission/1/1918 PA-X
26. FACT subunit SUPT16H associates with BRD4 and contributes to silencing of antiviral interferon signaling
27. Rapid and Efficient Inactivation of SARS-CoV-2 from Surfaces using UVC Light Emitting Diode Device
28. Epitope classification and RBD binding properties of neutralizing antibodies against SARS-CoV-2 variants of concern
29. Contribution of SARS-CoV-2 accessory proteins to viral pathogenicity in K18 hACE2 transgenic mice
30. A metal ion orients mRNA to ensure accurate 2’-O ribosyl methylation of the first nucleotide of the SARS-CoV-2 genome
31. Immunogenicity and Protective Efficacy of an Intranasal Live-attenuated Vaccine Against SARS-CoV-2 in Preclinical Animal Models
32. Generation and Characterization of recombinant SARS-CoV-2 expressing reporter genes
33. Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters
34. Development of a high-throughput homogeneous AlphaLISA drug screening assay for the detection of SARS-CoV-2 Nucleocapsid
35. Rapidin vitroassays for screening neutralizing antibodies and antivirals against SARS-CoV-2
36. Rescue of SARS-CoV-2 from a single bacterial artificial chromosome
37. Lethality of SARS-CoV-2 infection in K18 human angiotensin converting enzyme 2 transgenic mice
38. SARS-CoV-2 infection leads to acute infection with dynamic cellular and inflammatory flux in the lung that varies across nonhuman primate species
39. Structural Basis of RNA Cap Modification by SARS-CoV-2 Coronavirus
40. A Large-scale Drug Repositioning Survey for SARS-CoV-2 Antivirals
41. A broad and potent H1-specific human monoclonal antibody produced in plants prevents influenza virus infection and transmission in guinea pigs
42. Snake deltavirus utilizes envelope proteins of different viruses to generate infectious particles
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.